Certified by Founder Lodge
Logos Capital
United States - Miami, Florida
INVESTOR
1 Disclosed Funding Rounds $41,500,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Logos Capital* is a global merchant finance firm focused on catalyzing regenerative revolutions Ecopreneurship through Venture Capital, Private Equity with nextgen family offices and blockcha
| Company | Date | Round | Raised |
|---|---|---|---|
 Parse Biosciences |
February, 15 ,2022 | Series B | $41,500,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
 858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
 Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
 Maze Therapeutics |
December, 04 ,2024 | Series D | $115,000,000 |
 Expedition Therapeutics |
October, 14 ,2025 | Series A | $16,000,000 |
Galoy
Kroo Bank
Bloom Group S.A.
Hubble Money
Artoh
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
